London, UK - 24 May 2019 - NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that, in accordance with AIM Rules 20 and 26, the Group's Annual Report and Accounts for the year ended 31 December 2018 and Notice of Annual General Meeting have been sent to shareholders today and are available on the Company's website in the Investor Relations section at http://www.netscientific.net/investors.
The Annual General Meeting of the Group will be held on Tuesday, 18 June 2019 at 12.00 p.m. at Ashurst LLP, 1 Duval Square, London Fruit and Wool Exchange, London E1 6PW, United Kingdom.
# # #
For more information, please contact:
Ian Postlethwaite, CEO
Tel: +44 (0)20 3514 1800
WHIreland (NOMAD, Financial Adviser and Broker)
Chris Fielding / Jessica Cave
Tel: +44 (0)20 7220 1666
NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
Top stories from the Proactive Investors UK newsroom:
ANGLE PLC (LON:AGL) has received positive results from its Parsortix FDA clinical study for metastatic breast cancer. The 400-subject clinical study will support an application for Class II regulatory clearance for Parsortix in the...